122 related articles for article (PubMed ID: 38432528)
1. Virtual clinical QT exposure-response studies - A translational computational approach.
Aguado-Sierra J; Dominguez-Gomez P; Amar A; Butakoff C; Leitner M; Schaper S; Kriegl JM; Darpo B; Vazquez M; Rast G
J Pharmacol Toxicol Methods; 2024; 126():107498. PubMed ID: 38432528
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Effect of 5 QT-Positive Drugs on the JTpeak Interval - An Analysis of ECGs From the IQ-CSRC Study.
Darpo B; Benson C; Brown R; Dota C; Ferber G; Ferry J; Jarugula V; Keirns J; Ortemann-Renon C; Pham T; Riley S; Sarapa N; Ticktin M; Zareba W; Couderc JP
J Clin Pharmacol; 2020 Jan; 60(1):125-139. PubMed ID: 31378962
[TBL] [Abstract][Full Text] [Related]
3. Translational pharmacokinetic-pharmacodynamic modeling of QTc effects in dog and human.
Parkinson J; Visser SA; Jarvis P; Pollard C; Valentin JP; Yates JW; Ewart L
J Pharmacol Toxicol Methods; 2013; 68(3):357-66. PubMed ID: 23567074
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs.
Ollerstam A; Visser SA; Duker G; Forsberg T; Persson AH; Nilsson LB; Björkman JA; Gabrielsson J; Al-Saffar A
J Pharmacol Toxicol Methods; 2007; 56(2):131-44. PubMed ID: 17689270
[TBL] [Abstract][Full Text] [Related]
5. Moxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study.
Morganroth J; Wang Y; Thorn M; Kumagai Y; Harris S; Stockbridge N; Kleiman R; Shah R
Br J Clin Pharmacol; 2015 Sep; 80(3):446-59. PubMed ID: 26011050
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of moxifloxacin and its concentration-QT interval relationship modeling in Chinese healthy volunteers.
Xu FY; Huang JH; He YC; Liang LY; Li LJ; Yang J; Yin F; Xu L; Zheng QS; Wang K
Acta Pharmacol Sin; 2017 Nov; 38(11):1580-1588. PubMed ID: 28713157
[TBL] [Abstract][Full Text] [Related]
7. Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial.
Johannesen L; Vicente J; Mason JW; Erato C; Sanabria C; Waite-Labott K; Hong M; Lin J; Guo P; Mutlib A; Wang J; Crumb WJ; Blinova K; Chan D; Stohlman J; Florian J; Ugander M; Stockbridge N; Strauss DG
Clin Pharmacol Ther; 2016 Feb; 99(2):214-23. PubMed ID: 26259627
[TBL] [Abstract][Full Text] [Related]
8. Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study.
Matz J; Graff C; Vainio PJ; Kallio A; Højer AM; Struijk JJ; Kanters JK; Andersen MP; Toft E
Clin Drug Investig; 2011 Nov; 31(11):799-811. PubMed ID: 21967071
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
[TBL] [Abstract][Full Text] [Related]
10. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
[TBL] [Abstract][Full Text] [Related]
11. Detecting moxifloxacin-induced QTc prolongation in thorough QT and early clinical phase studies using a highly automated ECG analysis approach.
Panicker GK; Karnad DR; Kadam P; Badilini F; Damle A; Kothari S
Br J Pharmacol; 2016 Apr; 173(8):1373-80. PubMed ID: 26784016
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys.
Watson KJ; Gorczyca WP; Umland J; Zhang Y; Chen X; Sun SZ; Fermini B; Holbrook M; Van Der Graaf PH
J Pharmacol Toxicol Methods; 2011; 63(3):304-13. PubMed ID: 21419854
[TBL] [Abstract][Full Text] [Related]
13. Clinical Trial in a Dish: Personalized Stem Cell-Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT-Prolonging Drugs.
Blinova K; Schocken D; Patel D; Daluwatte C; Vicente J; Wu JC; Strauss DG
Clin Transl Sci; 2019 Nov; 12(6):687-697. PubMed ID: 31328865
[TBL] [Abstract][Full Text] [Related]
14. Inter-study variability of preclinical in vivo safety studies and translational exposure-QTc relationships--a PKPD meta-analysis.
Gotta V; Cools F; van Ammel K; Gallacher DJ; Visser SA; Sannajust F; Morissette P; Danhof M; van der Graaf PH
Br J Pharmacol; 2015 Sep; 172(17):4364-79. PubMed ID: 26076100
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of common marmosets to detect drug-induced QT interval prolongation: moxifloxacin case study.
Komatsu R; Honda M; Holzgrefe HH; Kubo J; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
J Pharmacol Toxicol Methods; 2010; 61(3):271-6. PubMed ID: 20097298
[TBL] [Abstract][Full Text] [Related]
16. Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.
Dixon R; Job S; Oliver R; Tompson D; Wright JG; Maltby K; Lorch U; Taubel J
Br J Clin Pharmacol; 2008 Sep; 66(3):396-404. PubMed ID: 18662287
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic-pharmacodynamic modelling of drug-induced QTc interval prolongation in man: prediction from in vitro human ether-à-go-go-related gene binding and functional inhibition assays and conscious dog studies.
Dubois VF; Casarotto E; Danhof M; Della Pasqua O
Br J Pharmacol; 2016 Oct; 173(19):2819-32. PubMed ID: 27427789
[TBL] [Abstract][Full Text] [Related]
18. No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block.
Thomsen MB; Beekman JD; Attevelt NJ; Takahara A; Sugiyama A; Chiba K; Vos MA
Br J Pharmacol; 2006 Dec; 149(8):1039-48. PubMed ID: 17088870
[TBL] [Abstract][Full Text] [Related]
19. QT prolongation and proarrhythmia by moxifloxacin: concordance of preclinical models in relation to clinical outcome.
Chen X; Cass JD; Bradley JA; Dahm CM; Sun Z; Kadyszewski E; Engwall MJ; Zhou J
Br J Pharmacol; 2005 Nov; 146(6):792-9. PubMed ID: 16158069
[TBL] [Abstract][Full Text] [Related]
20. Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects.
Taubel J; Ferber G; Lorch U; Batchvarov V; Savelieva I; Camm AJ
Br J Clin Pharmacol; 2014 Jan; 77(1):170-9. PubMed ID: 23713767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
